Shows how much you know.
1) You state a company is at $128/share but don't mention the market cap....I mean this is what I'm talking about, you need a FIN101 course clearly
2) Paralysis by analysis? That's funny, don't think I've ever seen anyone on ihub do real analysis...make be that's just a tad harsh, but you get my gist, there's def not any real analysis being done on this ticker to justify it being worth $15M!!!! Lmaoooo. I'm an analyst by trade so please leave that garbage for some other noob like yourself.
Bud, never once have I heard one legitimate argument as to why this company can be considered a healthy investment.
I put the emphasis on HEALTY, their income statement and balance sheet and putrid and they're moving at the speed of a snail (that's just the way it is with pharma, not their fault, unless of course proscavax is a total waste of time, which in fact most drugs don't make it past phase 2 if they're like to pass phase 1). They don't have a way to keep going long term without more toxic financing, they just don't. I'll keep mentioning that anytime anyone tries to pump this with absolutely no real insight or logic other than "hey well um this is like supposed to be worth like $1 and $5M in debt isn't that bad, u yeah gee oh boy yea."
Enjoy getting no bids and outasked by vndm, puma, nite and all their friends. Bag holders galore, i promise you.
News 
Market Data 
Discover 
AI
